Biomemory launches DNA Shield, first commercial product on molecular IT platform

Biomemory has launched DNA Shield, its first commercial product built on its molecular IT platform, following the acquisition of catalog's assets and the appointment of Laurent Guengant as CEO. The product likely represents a commercial milestone for DNA-based data storage, though details on technical specifications and market impact remain limited. This signals early commercialization of an emerging technology with potential long-term implications for data storage.